La asociación propinox-clonixinato de lisina en dolor abdominal agudo

Prensa Medica Argentina

Volumn 86, Issue 7, 1999, Pages 698-705

  Alvarez, Juan ^a   Ferreres, Alberto ^a   Greggio, Andrés ^a   Marrone, Walter ^a   Del Prete, Claudio ^a   Giglio, Norberto ^a   Pellegrini, Horacio ^a   Alvarez, Claudio ^a   Macri, Silvia Pérez ^a   Argüello, Susana Pastor ^a   Tartas, Haydeé ^a   Giunta, Daniel ^a   Vázquez, Jesús ^a   Sureda, Luis ^a   Quintana, Eduardo Valdés ^a   Morano, Miguel ^a   Godoy, María Inés ^a   Palomino, Gloria ^a   Fandiño, Daniel ^a   Zmijanovich, Rogelio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PARACETAMOL; PROPINOX PLUS CLONIXIN LYSINE; SCOPOLAMINE BUTYL BROMIDE; SPASMOLYTIC AGENT; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL TRIAL; COLIC; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0032707781     PISSN: 0032745X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. CHRISTENSEN J.: Pathophisiology of the irritable bowel syndrome. Lancet, 340: 1444-1452, 1992.
2. DROSSMAN D.A, THOMPSON W.C.: The irritable bowel syndrome: Review and a graduated multicomponent approach. An. Int. Med., 116 (12) Part. 1:1009-1016, 1992.
3. THOMPSON W.G.: Irritable bowel syndrome: pathogenesis and management. Lancet, 341: 1569-1572, 1993.
4. ATTARD A.L; CORLETT M.J.; KIDNER N.J.; LESLIE A.P.; FRASE I.A.: Safety of early pain relief for acute abdominal pain. BMJ, 305: 554-556, 1992.
5. BAISTROCCHI R.; ORTÍ E.; DE LOS SANTOS A.R.; DI GIROLAMO G.; MARTÍ M.L; PICO J.C.: Antispasmodic action of propinox hydrochloride (P) on the gallbladder. Possible mechanism of action. Medicina, 57 (Supl.4): 61, 1997.
6. 14C arachidonic acid in the human articular cartilage. En: IV World Conference on Clinical Pharmacology and Therapeutics, Mannheim-Heidelberg, Germany, July 23-28, 1989.
7. FRANCHI A.; DI GIROLAMO G.; DE LOS SANTOS A.R.; MARTI M.L; GIMENO M.: Effects of lysine clonixinate (LC) on cyclooxigenase (COX) I and II in rat lung preparations. En: APPTLA - CPT 96: 198, VI World Conference on Clinical Pharmacology and Therapeutics. (Abstract 633) Buenos Aires, Argentina. August 4-9. 1996.
8. th International Conference on Prostaglandins and Related Compounds. Viena, Austria. September 22-27, 1996.
9. PICO J.C.; DE BUACAR R.N.W.; GALLO PECCA J.; MARTÍNEZ M.: Contribución al estudio de la farmacocinética del Clonixinato de lisina en un modelo multicompartimental. Pren. Méd. Arg., 64: 20-24, 1977.
10. PICO J.C.; MONTI C.E.; DE BUACAR R.N.W.; MARTÍNEZ M.; ALDOMÁ G.E.; MITTA A.E.: Pharmacokinetic study of 2- (2′-methyl-3′-chloro anilino) lysine nicotinate (L-104). Arzneim Forsch, 31 (II) (7): 1127-1130, 1981.
11. BIDLINCMAIER A.; HAMMERMAIER A.; NAGYIVÁNYI P.; PABST G.; WAITZINGER J.: Gastrointestinal blood loss induced by three different nonsteroidal anti-inflammatory drugs. Arzneim Forsch, 45 (II) (4): 491-493, 1995.
12. FRANCHI A.M.; DI GIROLAMO G.; DE LOS SANTOS A.R.; MARTÍ M.L.; GIMENO M.A.F.: Effects of lysine clonixinate on cyclooxygenase I and II in rat lung and stomach preparations. Prostaglandins Leukot. Essent. Fatty Acids, 58 (6): 421-424, 1998.
13. CASTILLO R.: Propinox más clonixinato de lisina por via oral en dolor cólico abdominal. Pren. Méd. Argent., 84: 126-133, 1997.
14. SUREDA L.M.J.; TARTAS H.N.; DEL PRETE C.; GREGGIO A.J.: Evaluación de la eficacia y tolerancia de la asociación de propinox con clonixinato de lisina en el dolor có lico abdominal. Pren. Méd. Argent, 85: 1146-1150, 1998.
15. a Asamblea Médica Mundial 1989 - Hong Kong).